| Literature DB >> 3422179 |
A J Jacobs1, G M Sommers, J H Axelrod, A E Galakatos, M S Kao, H M Camel.
Abstract
The serum copper and CA 125 levels of 31 patients with epithelial ovarian carcinoma were determined. Serum copper was elevated in seven patients and CA 125 was elevated in 22 patients. A rise in serum CA 125 always was associated with disease progression. In comparison, serum copper fluctuation did not correlate with the natural history of the malignancy. We concluded that serum copper determination has no use in epithelial ovarian carcinoma management.Entities:
Mesh：
Substances：
Year: 1988 PMID： 3422179 DOI： 10.1002/1097-0142(19880301)61:5<1015::aid-cncr2820610526>3.0.co;2-t
Source DB: PubMed Journal: Cancer ISSN： 0008-543X Impact factor: 6.860